Iberoamerican Journal of Medicine
https://iberoamjmed.com/article/doi/10.5281/zenodo.4095782
Iberoamerican Journal of Medicine
Review

Implementation of good pharmacy practice standards; a step forward in Libya’s pharmacies

Shukri M. Alsharif, Saadoun O. Elmezughi, Fathi M. Sherif

Downloads: 5
Views: 1459

Abstract

The practice of pharmacy in health care societies continues to undergo evolutionary and even radical changes. It has changed to a personal health service charged with assuring pharmaceutic and therapeutic appropriateness of all its functions in the care of patients. The purpose of this study is to review and analysis the historical stages of development of the good pharmaceutical practice (GPP) requirements and to recommend a guideline for the implementation of GPP standards in Libya as a way to improve the pharmaceutical care and profession. The study designates that the development of the GPP standards should be committed at the public professional organizations levels as pharmaceutical syndicates and associations as the national regulation of pharmacy practices in various countries and the local health authorities. This requires basic skills of documentation, professional and communication with all relative professions and it, therefore, is important to establish standards for community, hospital and consultant pharmacists to promote the pharmaceutical mission.

Keywords

Libya; Pharmacies; Pharmacist; WHO

References

1. World Health Organization. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for quality of pharmacy services. Annex 8. 2011; Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/FIPWHOGuidelinesGoodPharmacyPracticeTRS961Annex8.pdf (accessed June 2020).
2. van Mil JW, Schulz M, Tromp TF. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review. Pharm World Sci. 2004;26(6):303-11. doi: 10.1007/s11096-004-2849-0.
3. The Order of MOH of Ukraine of 30.05.2013 № 455. On Approval of the Guidelines Good Pharmacy Practice: Quality Standards Pharmacy Services. Weekly Pharm. 2013;27:18-20.
4. Elfituri A, Almoudy A, Jbouda W, Abuflaiga W, Sherif FM. Libya’s Pharmaceutical Situation: A Professional Opinion: Int J Academic Health Med Res. 2018;2(10):5-9.
5. Alsharif SM, Khalf AM, Sughir AA, El-Attug MN, Ammar AA, Kamur RM. Performance assessment of community pharmacist’s intervention in quality of care in Tripoli, Libya: A cross-sectional study: Lebda Med J. 2016;2:61-4.
6. El Oakley RM, Ghrew MH, Aboutwerat AA, Alageli NA, Neami KA, Kerwat RM, et al. Consultation on the Libyan health systems: towards patient-centred services. Libyan J Med. 2013;8. doi: 10.3402/ljm.v8i0.20233.
7. Wiedenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M. Developing a pharmacy practice. A focus on patient care (2006 Edition). World Health Organization and International Pharmaceutical Federation. Available from: https://www.fip.org/files/fip/publications/DevelopingPharmacyPractice/DevelopingPharmacyPracticeEN.pdf (accessed June 2020).
8. Correia JC, Lachat S, Lagger G, Chappuis F, Golay A, Beran D; COHESION Project. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health. 2019;19(1):1542. doi: 10.1186/s12889-019-7842-6.
9. Hohmeier KC, Wheeler JS, Turner K, Vick JS, Marchetti ML, Crain J, Brookhart A. Targeting adaptability to improve Medication Therapy Management (MTM) implementation in community pharmacy. Implement Sci. 2019;14(1):99. doi: 10.1186/s13012-019-0946-7.
10. Nazar H, Nazar Z, Portlock J, Todd A, Slight SP. A systematic review of the role of community pharmacies in improving the transition from secondary to primary care. Br J Clin Pharmacol. 2015;80(5):936-48. doi: 10.1111/bcp.12718.
11. Barber N, Smith F, Anderson S. Improving quality of health care: the role of pharmacists. Qual Health Care. 1994;3(3):153-8. doi: 10.1136/qshc.3.3.153.
12. Bradley CP. The future role of pharmacists in primary care. Br J Gen Pract. 2009;59(569):891-2. doi: 10.3399/bjgp09X473105.
13. Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK - a literature review of current practice and research. J Clin Pharm Ther. 2007;32(6):545-56. doi: 10.1111/j.1365-2710.2007.00867.x.
14. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-25. doi: 10.7326/0003-4819-146-10-200705150-00005.
15. Kamusheva M, Ignatova D, Golda A, Skowron A. The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View. Integr Pharm Res Pract. 2020;9:49-63. doi: 10.2147/IPRP.S239672.
16. Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm. 2019;15(9):1057-67. doi: 10.1016/j.sapharm.2018.09.021.
17. Saleem F, Hassali MA, Shafie AA, Ul Haq N, Farooqui M, Aljadhay H, et al. Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial. Health Expect. 2015;18(5):1270-81. doi: 10.1111/hex.12101.
18. Bell SK, Langer T, Luff D, Rider EA, Brandano J, Meyer EC. Interprofessional Learning to Improve Communication in Challenging Healthcare Conversations: What Clinicians Learn From Each Other. J Contin Educ Health Prof. 2019;39(3):201-9. doi: 10.1097/CEH.0000000000000259.
19. Mahajan R, Mohammed CA, Sharma M, Gupta P, Singh T. Interprofessional Education: An Approach to Improve Healthcare Outcomes. Indian Pediatr. 2018;55(3):241-9.
20. Figge H. Engaging the patient: Tools and Techniques: US Pharm. 2016;41(8):55-7.
21. Yong FR, Garcia-Cardenas V, Williams KA, Charlie Benrimoj SI. Factors affecting community pharmacist work: A scoping review and thematic synthesis using role theory. Res Social Adm Pharm. 2020;16(2):123-41. doi: 10.1016/j.sapharm.2019.05.001.
22. Hassali MA, Mak VLS, See OG: Pharmacy practice in Malaysia. J Pharmacy Practice Res. 2014;44(3): 125-8. doi: 10.1002/jppr.1024.
23. Bhuvan KC. Curriculum Development: Mismatch Between Supply and Demand. In: Fathelrahman AI, Ibrahim MIM, Alrasheedy AA, Wertheimer AI. Pharmacy Education in the Twenty First Century and Beyond. Elsevier Inc; 2018:285-96. doi: 10.1016/C2016-0-02069-7.
24. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71-9. doi: 10.1111/j.2042-7174.2011.00164.x.
25. Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Björnsdóttir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32(4):472-87. doi: 10.1007/s11096-010-9393-x.
26. Jackson J, Caliph S, Chui WK, Ocampo L. Using a collaborative decision-making approach to identify, prioritise and respond to issues influencing Good Pharmacy Practice across countries of the Western Pacific Region. Int J Pharm Pract. 2020;28(3):282-9. doi: 10.1111/ijpp.12588.
27. George PP, Molina JA, Cheah J, Chan SC, Lim BP. The evolving role of the community pharmacist in chronic disease management - a literature review. Ann Acad Med Singap. 2010;39(11):861-7.
28. World Health Organization. Regional Office for Europe. 2002 . Good pharmacy practice in the newly independent states: manual on development and implementation of standards. Copenhagen: WHO Regional Office for Europe. Available from: https://apps.who.int/iris/handle/10665/107443 (accessed April 2020).
29. FIP Reference Guide on Good Pharmacy Practice in Community and Hospital Settings. First edition 2009/ Approved by FIP Council in Istanbul in September 2009. The Hague, Netherlands: International Pharmaceutical Federation Internationale Pharmaceutique; 2009:62. Avilable from: https://www.fip.org/files/content/publications/2009/Final_GPP_reference_paper_Final.pdf (accessed Sept. 2020).
30. orld Health Or ani ation. 2011 . Forty-fifth report of the WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/44079 (accessed Sept. 2020).
31. World Health Organization. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services from the WHO Technical Report Series, No. 961, 45th Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations © World Health Organization; 2011:20. Available from: https://www.fip.org/files/fip/WHO/GPP%2520guidelines%2520FIP%2520publication_final.pdf (accessed Sept. 2020).


Submitted date:
09/28/2020

Reviewed date:
10/16/2020

Accepted date:
10/16/2020

Publication date:
10/16/2020

5f89e5e60e88258d02016d4c iberoamericanjm Articles
Links & Downloads

Iberoam J Med

Share this page
Page Sections